To Treat or Not to Treat: That Is the Question for Serum (original) (raw)

• Article
• Published: 01 April 1995

Bio/Technology volume 13, pages 334–337 (1995)Cite this article

• 251 Accesses
• 29 Citations
• Metrics details

Abstract

As regulations on serum importation stagnate, the industry moves toward treatment options

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

Similar content being viewed by others

References

1. APHIS. 1994. Importation of fetal bovine serum. Federal Register 59: (38) 9142–9146.
2. Hodgson, J. 1993. Fetal bovine serum revisited. Bio/Technology 11: 49–53.
   CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

1. articles editor of Bio/Technology,
   John Hodgson

Rights and permissions

About this article

Cite this article

Hodgson, J. To Treat or Not to Treat: That Is the Question for Serum.Nat Biotechnol 13, 334–337 (1995). https://doi.org/10.1038/nbt0495-333

Download citation

• Issue date: 01 April 1995
• DOI: https://doi.org/10.1038/nbt0495-333

This article is cited by

• A plea to reduce or replace fetal bovine serum in cell culture media

  • Gerhard Gstraunthaler
  • Toni Lindl
  • Jan van der Valk
    Cytotechnology (2013)